US Stock MarketDetailed Quotes

ONCT Oncternal Therapeutics

Watchlist
  • 7.1400
  • +0.0900+1.28%
Trading Jul 3 09:53 ET
21.13MMarket Cap-579P/E (TTM)

Oncternal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oncternal Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-2.83

+27.99%
Analyst Rating

Buy

Jun 30, 2024

Oncternal Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 158.330K--
--2024/Q2-- / 158.330K--
May 9, 20242024/Q1569.000K / 132.500K--
Mar 7, 20242023/Q4297.000K / 137.500K--
Nov 9, 20232023/Q3179.000K / 125.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 158.330K--
--2024/Q2-- / 158.330K--
May 9, 20242024/Q1569.000K / 132.500K--
Mar 7, 20242023/Q4297.000K / 137.500K--
Nov 9, 20232023/Q3179.000K / 125.000K--

Unlock Free Earnings Estimates

Oncternal Therapeutics Earnings Reports

  • Oncternal Therapeutics | 10-Q: Quarterly report

    May 9 16:25 ET

  • Oncternal Therapeutics | 10-K: Annual report

    Mar 7 16:25 ET

  • Oncternal Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:30 ET

  • Oncternal Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg